FFP Dosing
FFP 10-15 mL/kg for INR correction. Higher doses for INR >4. PCC preferred for urgent warfarin reversal.
Why This Health Metric Matters
Why: Proper FFP dosing corrects coagulopathy. PCC offers faster reversal when indicated.
How: Enter weight, current/target INR. Dose based on 10-15 mL/kg; units = mL รท 225.
- โ10-15 mL/kg standard
- โPCC for urgent reversal
- โVitamin K concurrent
Clinical Scenarios
๐ Warfarin Reversal - Urgent
Urgent surgery in anticoagulated patient
๐ฉธ Life-Threatening Bleeding
Major hemorrhage on anticoagulation
๐ฅ Liver Disease Coagulopathy
Cirrhosis with elevated INR
๐จ Massive Transfusion
Trauma with massive hemorrhage
โ ๏ธ DIC with Bleeding
Disseminated intravascular coagulation
๐ Minor Procedure
Central line placement
๐งฌ Factor Deficiency
Multiple factor deficiency
๐ Vitamin K Deficiency
Nutritional or antibiotic-related
Patient & INR Information
Clinical Context
โ ๏ธFor informational purposes only โ not medical advice. Consult a healthcare professional before acting on results.
๐ฅ Health Facts
~225 mL per unit
โ Transfusion
30-45 min thaw
โ Blood bank
Understanding Fresh Frozen Plasma
Fresh Frozen Plasma (FFP) contains all coagulation factors at approximately 1 IU/mL. It is used to correct multiple factor deficiencies, reverse warfarin, and treat coagulopathies. Understanding proper dosing and alternatives is essential for effective transfusion therapy.
Fresh Frozen Plasma (FFP)
- Volume: 200-250 mL per unit
- Thaw Time: 30-45 minutes
- Shelf Life: 24 hours after thaw (1-6ยฐC)
Thawed Plasma
- Volume: 200-250 mL per unit
- Thaw Time: Pre-thawed
- Shelf Life: 5 days after thaw
Cryoprecipitate
- Volume: 15-20 mL per unit (pooled)
- Thaw Time: 10-15 minutes
- Shelf Life: 6 hours after thaw (pooled)
4-Factor PCC (Kcentra)
- Volume: ~20-40 mL per vial
- Thaw Time: Ready to use
- Shelf Life: 4 hours after reconstitution
Appropriate Indications for FFP
โ Appropriate Uses
- โข Warfarin reversal (with Vitamin K)
- โข Massive transfusion protocol
- โข DIC with active bleeding
- โข Multiple factor deficiencies
- โข Liver disease with bleeding
- โข TTP (plasma exchange)
โ Inappropriate Uses
- โข Volume expansion (use crystalloid)
- โข Nutritional supplementation
- โข Wound healing
- โข Prophylaxis without elevated INR
- โข Mild INR elevation without bleeding
- โข Single factor deficiency (use specific factor)
Alternative Therapies
4-Factor PCC (Kcentra)
Indication: Warfarin reversal, urgent surgery, life-threatening bleeding
Dose: Based on INR: 25-50 units/kg
โ Cost, thrombotic risk, not for liver disease
Vitamin K (Phytonadione)
Indication: Warfarin reversal (non-urgent), prevention of re-elevation
Dose: 1-10 mg IV/PO based on urgency
โ Slow onset (6-24 hours), resistance to re-anticoagulation
rFVIIa (NovoSeven)
Indication: Refractory bleeding, hemophilia with inhibitors
Dose: 15-90 mcg/kg
โ Very expensive, thrombotic risk, short half-life
Fibrinogen Concentrate
Indication: Hypofibrinogenemia (<1.5 g/L with bleeding)
Dose: 25-50 mg/kg
โ Cost, only replaces fibrinogen
Transfusion Reactions to Monitor
Acute Reactions
- TACO - Transfusion-associated circulatory overload: dyspnea, hypertension, pulmonary edema
- TRALI - Transfusion-related acute lung injury: hypoxemia, bilateral infiltrates within 6h
- Allergic - Urticaria, pruritus, anaphylaxis (rare)
- Febrile - Temperature rise โฅ1ยฐC during/after transfusion
- Hemolytic - Rare with FFP, but monitor for ABO incompatibility signs
Prevention & Management
- TACO Prevention - Slow infusion rate, diuretics if at risk
- TRALI Prevention - Use male-only plasma when possible
- Allergic - Antihistamines, stop transfusion if severe
- Monitoring - Vital signs q15min for first hour
- Documentation - Report all reactions to blood bank
4-Factor PCC (Kcentra) Dosing Guide
For urgent warfarin reversal, 4-Factor PCC provides faster and more complete correction than FFP alone. PCC is preferred for life-threatening bleeding or emergent surgery in anticoagulated patients.
| Pre-Treatment INR | PCC Dose (units/kg) | Max Dose (units) | Notes |
|---|---|---|---|
| 2.0 - <4.0 | 25 units/kg | 2500 units | Give with Vitamin K 10mg IV |
| 4.0 - 6.0 | 35 units/kg | 3500 units | Check INR at 30 min |
| >6.0 | 50 units/kg | 5000 units | Consider additional FFP if needed |
Important: PCC has thrombotic risk. Avoid in patients with recent arterial/venous thrombosis, DIC, or HIT. Monitor for thromboembolism after administration. Always give Vitamin K concurrently to prevent INR rebound.
Vitamin K (Phytonadione) Dosing
Life-Threatening Bleeding
Slow infusion over 10-20 min. Repeat at 12h if INR still elevated.
Urgent (INR 5-9)
Check INR at 24h. Additional doses may be needed.
Non-Urgent (INR >10)
Hold warfarin, recheck INR in 24-48h.
Special Populations
Liver Disease
- โข INR may not accurately predict bleeding risk
- โข Balanced coagulopathy (decreased pro- and anticoagulants)
- โข FFP effect often transient and incomplete
- โข Consider TEG/ROTEM-guided therapy
- โข Fibrinogen replacement often more important
- โข Avoid prophylactic FFP for procedures when possible
Massive Transfusion
- โข Target 1:1:1 ratio of PRBC:FFP:Platelets
- โข Early empiric FFP before lab results available
- โข Maintain fibrinogen >1.5 g/L
- โข Consider tranexamic acid (TXA)
- โข Warm all blood products
- โข Monitor calcium (citrate toxicity)